Drugs intervention study in COVID-19 management

Bakhtiar, M. Taher and Tik, Noratika and Darnis, Deny Susanti (2021) Drugs intervention study in COVID-19 management. Drug Metabolism and Personalized Therapy. pp. 1-12. ISSN 2363-8907 E-ISSN 2363-8915

	PDF (Article) - Published Version Restricted to Registered users only Download (373kB) | Request a copy
	PDF (SCOPUS) - Supplemental Material Restricted to Registered users only Download (515kB) | Request a copy

Abstract

By 9 February 2021, the Coronavirus has killed 2,336,650 people worldwide and it has been predicted that this number continues to increase in year 2021. The study aimed to identify therapeutic approaches and drugs that can potentially be used as interventions in Coronavirus 2019 (COVID-19) management. A systematic scoping review was conducted. Articles reporting clinical evidence of therapeutic management of COVID-19 were selected from three different research databases (Google Scholar, PubMed, and Science Direct). From the database search, 31 articles were selected based on the study inclusion and exclusion criteria. This review paper showed that remdesivir and ivermectin significantly reduced viral ribonucleic acid (RNA) activity. On the other hand, convalescent plasma (CP) significantly improved COVID-19 clinical symptoms. Additionally, the use of corticosteroid increased survival rates in COVID-19 patients with acute respiratory distress syndrome (ARDS). Findings also indicated that both hydroxychloroquine and favipiravir were effective against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, lopinavir– ritonavir combination was not effective against COVID-19. Finally, ribavirin, galidesivir, and sofosbuvir showed potential therapeutic benefit in treating COVID-19, but there is a lack of clinical evidence on their effectiveness against SARS-CoV-2. Remdesivir, ivermectin, favipiravir, hydroxychloroquine, dexamethasone, methylprednisolone, and CP are the therapeutic agents that can potentially be used in COVID-19 management.

Item Type:	Article (Journal)
Additional Information:	5209/89238
Uncontrolled Keywords:	antiviral; clinical trial; COVID-19; drug inter-vention; SARS-CoV-2.
Subjects:	R Medicine > RS Pharmacy and materia medica
Kulliyyahs/Centres/Divisions/Institutes (Can select more than one option. Press CONTROL button):	Kulliyyah of Pharmacy Kulliyyah of Pharmacy > Department of Pharmaceutical Technology Kulliyyah of Science Kulliyyah of Science > Department of Chemistry
Depositing User:	Dr Muhammad Taher
Date Deposited:	13 Apr 2021 11:54
Last Modified:	01 Jul 2021 08:42
URI:	http://irep.iium.edu.my/id/eprint/89238

Actions (login required)

View Item